 The resulting murine antibodies are harvested and used to vaccinate other mice.The resulting antibodies in the second set of mice have a three-dimensional binding site that mimics the original antibodies that bind tumor-associated antigens.These antibodies are combined with an adjuvant and given as a vaccine.